We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVP icon
1401
Retractable Technologies
RVP
$19.8M
$25K ﹤0.01%
34,200
STCN
1402
DELISTED
Steel Connect, Inc. Common Stock
STCN
$22K ﹤0.01%
+1,093
New +$20.4K
NAVB
1403
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$20K ﹤0.01%
4,275
-28,219
-87% -$148K
JONE
1404
DELISTED
Jones Energy, Inc.
JONE
$16K ﹤0.01%
2,116
-17,602
-89% -$200K
YUMA
1405
DELISTED
Yuma Energy Inc
YUMA
$14K ﹤0.01%
1,685
BTX.WS
1406
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$1K ﹤0.01%
16,348
AHT
1407
Ashford Hospitality Trust
AHT
$20.9M
-213
Closed -$1.36M
AIRI icon
1408
Air Industries Group
AIRI
$13M
-6,580
Closed -$101K
ALG icon
1409
Alamo Group
ALG
$1.94B
-10,004
Closed -$1.1M
ALNY icon
1410
Alnylam Pharmaceuticals
ALNY
$27.5B
-54,000
Closed -$6.43M
ALT icon
1411
Altimmune
ALT
$552M
-1,421
Closed -$49K
OSG
1412
Octave Specialty Group
OSG
$243M
-85,500
Closed -$1.34M
APPS icon
1413
Digital Turbine
APPS
$975M
-829,200
Closed -$1.67M
ARWR icon
1414
Arrowhead Research
ARWR
$11.9B
-200,000
Closed -$1.44M
ASRT
1415
DELISTED
Assertio
ASRT
-718
Closed -$284K
AVTX icon
1416
Avalo Therapeutics
AVTX
$965M
-90
Closed -$1.11M
BAX icon
1417
Baxter International
BAX
$13.5B
-56,300
Closed -$3.66M
BHC icon
1418
Bausch Health
BHC
$2.58B
-16,000
Closed -$255K
CALX icon
1419
Calix
CALX
$2.26B
-50,000
Closed -$343K
CBOE icon
1420
Cboe Global Markets
CBOE
$32.5B
-26,300
Closed -$3M
CBRE icon
1421
CBRE Group
CBRE
$42.5B
-170,000
Closed -$8.03M
CCK icon
1422
Crown Holdings
CCK
$12.8B
-47,300
Closed -$2.4M
CECO icon
1423
Ceco Environmental
CECO
$3.85B
-33,022
Closed -$147K
CTAS icon
1424
Cintas
CTAS
$81.9B
-182,000
Closed -$7.76M
CWST icon
1425
Casella Waste Systems
CWST
$5.71B
-84,500
Closed -$1.98M

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.